← Back to Clinical Trials
Recruiting NCT04236492

NCT04236492 Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral Allografts

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04236492
Status Recruiting
Phase
Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition Osteochondral Defect
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2018-06-06
Primary Completion 2026-03-10

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 50 Years
Study Type OBSERVATIONAL
Interventions
Fresh osteochondral allografting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2018-06-06 with a primary completion date of 2026-03-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main objective of this study is to assess the clinical and radiological results after carrying out a transplant of fresh osteochondral allograft in the knee.

Eligibility Criteria

Inclusion Criteria: Patients undergoing cartilage repair with fresh osteochondral allograft transplantation for large focal full-thickness chondral and osteochondral defects (\>2 cm2) on the tibial plateau, femoral condyles, trochlea and/or patella Bipolar lesions are included. Exclusion Criteria: * BMI\> 30 kg / m2 * Systemic inflammatory diseases * Inflammatory arthritis * Advanced osteoarthritis * Tricompartmental degenerative process * Active infection * Patients who are unable to provide written informed consent.

Contact & Investigator

Central Contact

Àlex Grau Blanes

✉ agraub@santpau.cat

📞 +34935537031

Principal Investigator

Pablo Gelber

PRINCIPAL INVESTIGATOR

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Frequently Asked Questions

Who can join the NCT04236492 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 50 Years, studying Osteochondral Defect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04236492 currently recruiting?

Yes, NCT04236492 is actively recruiting participants. Contact the research team at agraub@santpau.cat for enrollment information.

Where is the NCT04236492 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT04236492 clinical trial?

NCT04236492 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The principal investigator is Pablo Gelber at Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology